← Back to Search

PET-CT Scans for Head and Neck Cancer

N/A
Recruiting
Led By John J Kim, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Non-nasopharynx head and neck mucosal squamous cell carcinoma
To be eligible for the second study PET-CT scan: FDG avid tumour (or minimum SUV of 2.5) on the first study PET-CT scan
Must not have
Inability to lie supine for study duration
Prior head and neck radiotherapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group

Summary

This trial is testing how well PET scans can help plan and give radiation therapy to people with head and neck cancer.

Who is the study for?
This trial is for adults with non-nasopharynx head and neck cancers who haven't had chemotherapy or radiotherapy in the last 5 years. They should have visible cancer that's treatable with radiation alone, and a tumor that shows up on PET scans. Pregnant individuals or those unable to consent are excluded.
What is being tested?
The study is testing how helpful PET scans are before and during radiation treatment for head and neck cancer patients. It aims to improve treatment planning by using additional PET scan data alongside routine tests.
What are the potential side effects?
While the trial focuses on imaging rather than drugs, potential side effects may include discomfort from lying still during the scan, anxiety from being in a confined space, and exposure to low levels of radiation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cancer is a type of squamous cell not in the nasopharynx area.
Select...
My tumor showed high activity on the initial PET-CT scan.
Select...
I am 18 years old or older.
Select...
I have received radiotherapy with the goal of curing my condition.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot lie on my back for an extended period.
Select...
I have had radiotherapy for head or neck cancer.
Select...
I have not had chemotherapy or EGFR inhibitors in the last 5 years.
Select...
My cancer has spread to distant parts of my body.
Select...
I have squamous cell carcinoma of the head and neck.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: HNSCC Patients receiving RTExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,521 Previous Clinical Trials
503,284 Total Patients Enrolled
John J Kim, MDPrincipal InvestigatorThe Princess Margaret Cancer Foundation

Media Library

18-F FDG Clinical Trial Eligibility Overview. Trial Name: NCT02678884 — N/A
Head and Neck Squamous Cell Carcinoma Research Study Groups: HNSCC Patients receiving RT
Head and Neck Squamous Cell Carcinoma Clinical Trial 2023: 18-F FDG Highlights & Side Effects. Trial Name: NCT02678884 — N/A
18-F FDG 2023 Treatment Timeline for Medical Study. Trial Name: NCT02678884 — N/A
~6 spots leftby Nov 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top